Back to search
FDAFDA · Food and drugs·Recall number F-1430-2017

Xambo, 80 boxes of bulk capsules. Each containing 12,053 capsules in each box.

Published February 8, 2017 · Recall initiated: January 11, 2017

Summary

FDA records food Class II recall F-1430-2017, published February 8, 2017 and initiated January 11, 2017. Recalling firm: West Coast Laboratories Inc; Status: Terminated; Reported quantity: 964,240 capsules; Lot: 361215. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

West Coast Laboratories is recalling Xambo and Devagrass because there may be presence of 1,3-dimethylamylamine (DMAA).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
West Coast Laboratories Inc
Distributor
Colombia, South America
Lot
361215
Risk classification
Class II
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was Xambo, 80 boxes of bulk capsules. Each containing 12,053 capsules in each box. recalled?

Yes. FDA published recall F-1430-2017 on February 8, 2017. Reported hazard: West Coast Laboratories is recalling Xambo and Devagrass because there may be presence of 1,3-dimethylamylamine (DMAA).

What should I do if I have this product?

Voluntary: Firm initiated · Letter